Bath emollients have ‘no benefit beyond standard eczema care for children’

Bath emollients have ‘no benefit beyond standard eczema care for children’

May 9 2018 A study has found no evidence of clinical benefit from including bath emollients in...

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

April 16 2018 Honey appears likely to help children’s cough more than diphenhydramine, a...

OTC Viagra Connect availability to widen following launch via Boots

OTC Viagra Connect availability to widen following launch via Boots

April 11 2018 Viagra Connect should be available from most pharmacies at the end of this week,...

MHRA issues warning over flammability of headlice treatments

MHRA issues warning over flammability of headlice treatments

March 9 2018 Pharmacists have been asked to tell customers about the risk of fire when discussing...

OTC industry proposes maximum level for vitamin D in food supplements

OTC industry proposes maximum level for vitamin D in food supplements

March 6 2018 Food supplement manufacturers are proposing to set the maximum dose of vitamin D at...

  • Bath emollients have ‘no benefit beyond standard eczema care for children’

    Bath emollients have ‘no benefit beyond standard eczema care for children’

    Wednesday, 09 May 2018 15:28
  • Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Monday, 16 April 2018 09:13
  • OTC Viagra Connect availability to widen following launch via Boots

    OTC Viagra Connect availability to widen following launch via Boots

    Wednesday, 11 April 2018 12:52
  • MHRA issues warning over flammability of headlice treatments

    MHRA issues warning over flammability of headlice treatments

    Friday, 09 March 2018 16:15
  • OTC industry proposes maximum level for vitamin D in food supplements

    OTC industry proposes maximum level for vitamin D in food supplements

    Tuesday, 06 March 2018 12:24

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

NanoReproAG logo450

NanoRepro AG is an innovative leader in development, manufacturing and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use, in the domestic and international markets. Since October 2008, NanoRepro has been publicly listed with its headquarters located in Marburg, Germany.

Our goal is to provide accuracy in self-diagnostics for rapid disease detection.

Self-diagnostics is a fast growing market shaped by the ever-increasing health conscious of the population and healthcare spending. Our rapid diagnostic tests offer significant advantages over all available competitive products due to our flexibility in product design, in-depth market understanding and best practices of just-in-time manufacturing. Our most important success factor is continuous optimization of manufacturing costs. We create values for our customers, shareholders and employees.

The company has currently 20 rapid diagnostic tests within the portfolio addressing various healthcare needs (family planning, preventive healthcare, allergies, infectious diseases, and point of care).

Products intended for home-use

OvuQuick250

 

 

 

OvuQUICK

GraviQUICK

 

GlutenCHECK

CholesterinCHECK

FertiQuick

 

 

 

 

 

 

 

FertiQUICK

VagiQUICK

 

 

 

VagiQUICK

MenoQUICK

GraviQUICK Frühtest

FOBCHECK

Heli C CHECK

 

 

 

 

Heli-C-CHECK

AlkoholTEST

MilkCHECK

AllergoCHECK

EierCHECK

Food Supplements Alphabiol Fertility, Alphabiol Pregnancy, Alphabiol Hair Plus, Alphabiol Skin & Hair, Alphabiol Cranberry, Alphabiol Menopause

 

B2B Products:

HIV-QUICK

Troponin I Test, Strep A-Test, Influenza A/B Test, Albumin Dipstick-Tube Test, D-Dimer Test

Philosophy and Vision

NanoRepro AG aims to provide the modern innovative rapid diagnostic tests of high-quality for the preventive health-care of every person. We belong to the leading German manufacturers in the sector of self-diagnostics.

In today's world there is an increasing interest in rapid diagnostic tests, and so the demand for such products is growing continuously. The steady raise of this medical market segment is expected in the future.

NanoRepro´s strong and experienced management and partner team ensures innovation strength, product quality and delivery security. Our employees are professionally trained in their field and thus, contribute to the success of the company. In order to meet the high quality requirements, our scientists are working closely with the institutions such as Philipps University of Marburg and Technical University of Munich. In terms of production, the company has a strong and exclusive strategic partnership with a highly experienced German manufacturer specialized in the field of rapid diagnostic tests. With regard to product design and marketing, we ensure maximum flexibility and short time to market. One of our key success factors is the continuous optimization of production costs.

NanoRepro AG is a highly interesting trade partner in regard to the possibility for the exclusive right of sales agreement.

NanoRepro AG aims to create an ever-growing value for its customers, shareholders and employees.

 

Management Board
Lisa Jüngst, CEO

Lisa Jüngst has been within works at NanoRepro AG since 2006. In April 2013, she was elected to the Board of Directors, and prior to that she had been responsible for the marketing, finance and personnel department as well as investor relations. In 2006, Lisa Jüngst was the first employee of the company, and so she brought the first rapid test of NanoRepro AG to market.

Lisa Jüngst studied business management at the University of Fulda. In 2006 she successfully graduated from the university with a degree in business administration. In addition, Lisa Jüngst is a member of the Young Entrepreneurs Alliance.

Please contact us, if you have any questions

NanoRepro AG
Untergasse 8
35037 Marburg
Tel.: +49 (0)6421 – 95 14 49
Fax: +49 (0)6421 – 95 14 51
E-Mail:
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.nano.ag

OTC News

May 23 2018 The Court of Appeal has commenced hearing a case around the Government’s cut in pharmacy funding and other changes to community pharmacy introduced in 2016.
May 21 2018  NHS England and Capita’s handling of primary care support services has been criticised in an official report. The National Audit Office has published a review saying that “NHS England and...